Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing
Open Access
- 12 May 2021
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 179 (9) , 1839-1856
Abstract
Metabolism is dynamically regulated to accompany immune cell function, and altered immunometabolism can result in impaired immune responses. Concomitantly, the pharmacological manipulation of metabolic processes offers an opportunity for therapeutic intervention in inflammatory disorders. The nicotinamide adenine dinucleotide (NAD+) is a critical metabolic intermediate that serves as enzyme cofactor in redox reactions, and is also used as a co‐substrate by many enzymes such as sirtuins, adenosine diphosphate ribose transferases and synthases. Through these activities, NAD+ metabolism regulates a broad spectrum of cellular functions such as energy metabolism, DNA repair, regulation of the epigenetic landscape and inflammation. Thus, the manipulation of NAD+ availability using pharmacological compounds such as NAD+ precursors can have immune‐modulatory properties in inflammation. Here, we discuss how the NAD+ metabolism contributes to the immune response and inflammatory conditions, with a special focus on multiple sclerosis, inflammatory bowel diseases and inflammageing.LINKED ARTICLES: This article is part of a themed issue on Inflammation, Repair and Ageing. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.9/issuetocKeywords
Funding Information
- Ministerio de Ciencia e Innovación (PID2019‐110511RB‐I00 to M.N.N)
- H2020 European Research Council (ERC‐2016‐StG 715322‐EndoMitTalk to M.M)
- European Regional Development Fund
- Fundación Ramón Areces
This publication has 153 references indexed in Scilit:
- Tryptophan hydroxylase-1 regulates immune tolerance and inflammationJournal of Experimental Medicine, 2012
- NAD+ Levels Control Ca2+ Store Replenishment and Mitogen-induced Increase of Cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 Channel Gating in Human T LymphocytesJournal of Biological Chemistry, 2012
- Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2–mediated reversal of T-cell toleranceProceedings of the National Academy of Sciences, 2012
- Poly(ADP-Ribose) Polymerase-1: A Novel Therapeutic Target in Necrotizing EnterocolitisPediatric Research, 2011
- Sirtuin-1 Targeting Promotes Foxp3 + T-Regulatory Cell Function and Prolongs Allograft SurvivalMolecular and Cellular Biology, 2011
- Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2–P2X7 pathwayJournal of Experimental Medicine, 2010
- Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAEPLOS ONE, 2009
- The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in miceJournal of Clinical Investigation, 2009
- Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent mannerNature Medicine, 2009
- Multiple sclerosisThe Lancet, 2008